Purdue Pharma, which is owned by the Sackler family, manufactures and markets OxyContin -- one of the prescription ...
NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive ...
The $7.4 billion settlement plan proposed by OxyContin maker Purdue Pharma and the Sackler family members who own the bankrupt firm has gained nearly unanimous creditor approval. More than ...
Creditors of Purdue Pharma voted in favor of the opioid maker’s proposal to exit bankruptcy and pay billions to communities and individuals who say they were harmed by the company’s addictive ...
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced that its Chapter 11 Plan of Reorganization (“Plan”) received support from more than 99% of voting creditors, ...